
Learn more about SKYRIZI® (risankizumab‐rzaa)
Do not use SKYRIZI if you are allergic to risankizumab-rzaa or any of the ingredients in SKYRIZI. See the Medication Guide or Consumer Brief Summary for a complete list of ingredients.
What is SKYRIZI? | SKYRIZI® (risankizumab-rzaa)
SKYRIZI (Sky-RIZZ-ee; skaɪ rɪz zi), an injection, is known as an interleukin-23 (IL-23) inhibitor. † It works inside your body to treat adults with moderate to severe Ps who can take injections, …
How Does SKYRIZI Work? - SKYRIZI® (risankizumab‐rzaa)
Do not use SKYRIZI if you are allergic to risankizumab-rzaa or any of the ingredients in SKYRIZI. See the Medication Guide or Consumer Brief Summary for a complete list of ingredients.
SKYRIZI® (risankizumab-rzaa): A Biologic Treatment for Psoriasis
Discover SKYRIZI, an FDA-approved biologic treatment for psoriasis. See full Safety and Prescribing Information.
What Is SKYRIZI® (risankizumab-rzaa) for Crohn’s Disease?
Mar 1, 2023 · Learn about SKYRIZI® for adults with moderate to severe Crohn’s disease and if it may be right for you. See full Safety and Prescribing Info.
SKYRIZI® (risankizumab-rzaa) for Adults with Moderate to Severe …
Learn about SKYRIZI® for adults with moderate to severe Crohn’s disease. See full Safety and Prescribing Information.
Ways to Save on SKYRIZI® (risankizumab‐rzaa) for PS & PsA
Skyrizi Complete Savings Card Terms & Conditions Terms and Conditions apply. This benefit covers SKYRIZI ® (risankizumab-rzaa) alone or, for psoriatic arthritis patients, SKYRIZI plus …
SKYRIZI® (risankizumab-rzaa) Dosing for Ps and PsA
Find the dosing schedule for SKYRIZI and read about the options available for administering treatment for Ps and PsA. See Full Safety & Prescribing Info.
Possible Side Effects | SKYRIZI® (risankizumab-rzaa)
Find important SKYRIZI safety information & learn about the potential side effects of SKYRIZI treatment for Ps and PsA. See Full Safety & Prescribing Info.
What Is Crohn’s Disease? - SKYRIZI® (risankizumab-rzaa)
A Biologic for Crohn’s Disease SKYRIZI is the first treatment for Crohn’s that specifically targets the interleukin-23 (IL-23) protein, which is one of the key proteins responsible for inflammation. …